Sarepta Therapeutics, Inc. (LON:0L35)
54.32
+0.47 (0.87%)
At close: Apr 17, 2025
Sarepta Therapeutics Employees
Sarepta Therapeutics had 1,372 employees as of December 31, 2024. The number of employees increased by 58 or 4.41% compared to the previous year.
Employees
1,372
Change (1Y)
58
Growth (1Y)
4.41%
Revenue / Employee
1.11M GBP
Profits / Employee
136.95K GBP
Market Cap
4.35B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 94,300 |
GSK plc | 68,629 |
Haleon | 24,561 |
Smith & Nephew | 17,349 |
ConvaTec Group | 10,489 |
Hikma Pharmaceuticals | 9,500 |
HUTCHMED (China) | 1,811 |
Oxford Nanopore Technologies | 1,315 |
Sarepta Therapeutics News
- 9 days ago - INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sarepta Therapeutics, Inc. - SRPT - PRNewsWire
- 12 days ago - Sarepta Therapeutics Inc (SRPT) Under Investigation for Potential Securities Law Violations | ... - GuruFocus
- 12 days ago - SRPT Investigation: Kessler Topaz Meltzer & Check, LLP Encourages Sarepta Therapeutics, Inc. (NASDAQ: SRPT) Investors with Significant Losses to Contact the Firm - PRNewsWire
- 15 days ago - NASDAQ: SRPT Investigation Reminder: Kessler Topaz Meltzer & Check, LLP Encourages Sarepta Therapeutics, Inc. (NASDAQ: SRPT) Investors with Significant Losses to Contact the Firm - Business Wire
- 17 days ago - INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sarepta Therapeutics, Inc. - SRPT - GlobeNewsWire
- 20 days ago - Sarepta Therapeutics Stock Falls as Some Trials Halted After Patient Death - Investopedia
- 20 days ago - Sarepta halts three studies testing gene therapy for muscle disorder - Reuters
- 20 days ago - Sarepta Therapeutics Provides Update on ELEVIDYS - Business Wire